If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Angelo Colleoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 31 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
letrozole Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2020

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

Kolberg, H. C., Colleoni, M., Demetriou, G. S., Santi, P., Tesch, H., Fujiwara, Y., Tomasevic, Z. & Hanes, V., Jan 1 2020, (Accepted/In press) In : Drug Safety.

Research output: Contribution to journalArticle

Open Access
Biosimilar Pharmaceuticals
Breast Neoplasms
Safety
Stroke Volume
human ERBB2 protein
Open Access
letrozole
Lymph Nodes
Quality of Life
Clinical Trials
Breast Neoplasms

Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial

BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Hormones
Breast Neoplasms
Disease-Free Survival

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Ruhstaller, T., Giobbie-Hurder, A., Colleoni, M., Jensen, M-B., Ejlertsen, B., de Azambuja, E., Neven, P., Láng, I., Jakobsen, E. H., Gladieff, L., Bonnefoi, H., Harvey, V. J., Spazzapan, S., Tondini, C., Del Mastro, L., Veyret, C., Simoncini, E., Gianni, L., Rochlitz, C., Kralidis, E. & 10 others, Zaman, K., Jassem, J., Piccart-Gebhart, M., Di Leo, A., Gelber, R. D., Coates, A. S., Goldhirsch, A., Thürlimann, B., Regan, M. M. & Group, M. O. T. BIG. . C. G. A. T. I. B. C. S., Jan 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Breast
Hormones
Breast Neoplasms

A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB)

Mayer, I. A., Prat, A., Egle, D., Blau, S., Alejandro Perez Fidalgo, J., Gnant, M., Fasching, P. A., Colleoni, M., Wolff, A. C., Winer, E. P., Singer, C. F., Hurvitz, S., Estevez, L. G., Van Dam, P. A., Kummel, S., Mundhenke, C., Holmes, F., Babbar, N., Charbonnier, L., Diaz-Padilla, I. & 3 others, Vogl, F. D., Sellami, D. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 10, p. 2975-2987 13 p.

Research output: Contribution to journalArticle

Open Access
letrozole
Hormones
Breast Neoplasms
Placebos
Exanthema